Shiga International Patent Office

Masato Iida of Shiga International Patent Office explains the patent eligibility of AI-related inventions in Japan

Kenji Tanaka of Shiga International Patent Office conducts a statistical analysis of the effectiveness of arguments for inventive step in the Japan Patent Office examination

Amid the coronavirus pandemic, pioneering pharmaceutical makers, research institutes, and universities are working in collaboration to develop novel antiviral drugs that are small compounds and vaccines. Although most inventions produced this year will be disclosed when their patent applications are published next year, the inventions being developed before this pandemic have already been disclosed.

Shimpei Kuroda of Shiga analyses data on applications for AI inventions, examining AI’s use in fields as various as traffic control and medical diagnosis